A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD

Nonalcoholic fatty liver disease (NAFLD) is a major health problem, and its prevalence has increased in recent years, concurrent with rising rates of obesity and other metabolic diseases. Currently, there are no FDA‐approved pharmacological therapies for NAFLD, and lifestyle interventions, including...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Obesity (Silver Spring, Md.) Md.), 2020-10, Vol.28 (10), p.1843-1852
Hauptverfasser: Moore, Mary P., Cunningham, Rory P., Dashek, Ryan J., Mucinski, Justine M., Rector, R. Scott
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1852
container_issue 10
container_start_page 1843
container_title Obesity (Silver Spring, Md.)
container_volume 28
creator Moore, Mary P.
Cunningham, Rory P.
Dashek, Ryan J.
Mucinski, Justine M.
Rector, R. Scott
description Nonalcoholic fatty liver disease (NAFLD) is a major health problem, and its prevalence has increased in recent years, concurrent with rising rates of obesity and other metabolic diseases. Currently, there are no FDA‐approved pharmacological therapies for NAFLD, and lifestyle interventions, including weight loss and exercise, remain the cornerstones for treatment. Manipulating diet composition and eating patterns may be a sustainable approach to NAFLD treatment. Dietary strategies including Paleolithic, ketogenic, Mediterranean, high‐protein, plant‐based, low‐carbohydrate, and intermittent fasting diets have become increasingly popular because of their purported benefits on metabolic disease. This review highlights what is currently known about these popular dietary approaches in the management of NAFLD in clinical populations with mechanistic insight from animal studies. It also identifies key knowledge gaps to better inform future preclinical and clinical studies aimed at the treatment of NAFLD.
doi_str_mv 10.1002/oby.22964
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7511422</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2446727991</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4434-d4408e5cd457e54dafe02cab7006abb7dd336ff271aea131319db580b1cede8f3</originalsourceid><addsrcrecordid>eNp1kV1LwzAUhoMofkwv_AMS8EYv5vLVpr1R5uZUHE5QQa9C2pxqpWtm0k32741OhwqSixOSh4f38CK0S8kRJYR1bDY_YiyNxQrapCknbcnTh9XlPaEbaMv7F0JETCK6jjY4S1IuongTXXXxQBvcWBumO8H9Ehrt5vi2cbqBpxI8LqzDzTPgGwczqJvS1ljXBt850M04PGBb4OvuYNjfRmuFrjzsfM0Wuh-c3fUu2sPR-WWvO2znQnDRNkKQBKLciEhCJIwugLBcZ5KQWGeZNIbzuCiYpBo05eGkJosSktEcDCQFb6HjhXcyzcZg8pDB6UpNXDkO0ZXVpfr9U5fP6snOlIwoFYwFwcGXwNnXKfhGjUufQ1XpGuzUKxYSxrHkPAno_h_0xU5dHdb7oGLJZJrSQB0uqNxZ7x0UyzCUqI-KVKhIfVYU2L2f6ZfkdycB6CyAt7KC-f8mNTp9XCjfASJDmog</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2446727991</pqid></control><display><type>article</type><title>A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD</title><source>MEDLINE</source><source>Wiley Free Archive</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Moore, Mary P. ; Cunningham, Rory P. ; Dashek, Ryan J. ; Mucinski, Justine M. ; Rector, R. Scott</creator><creatorcontrib>Moore, Mary P. ; Cunningham, Rory P. ; Dashek, Ryan J. ; Mucinski, Justine M. ; Rector, R. Scott</creatorcontrib><description>Nonalcoholic fatty liver disease (NAFLD) is a major health problem, and its prevalence has increased in recent years, concurrent with rising rates of obesity and other metabolic diseases. Currently, there are no FDA‐approved pharmacological therapies for NAFLD, and lifestyle interventions, including weight loss and exercise, remain the cornerstones for treatment. Manipulating diet composition and eating patterns may be a sustainable approach to NAFLD treatment. Dietary strategies including Paleolithic, ketogenic, Mediterranean, high‐protein, plant‐based, low‐carbohydrate, and intermittent fasting diets have become increasingly popular because of their purported benefits on metabolic disease. This review highlights what is currently known about these popular dietary approaches in the management of NAFLD in clinical populations with mechanistic insight from animal studies. It also identifies key knowledge gaps to better inform future preclinical and clinical studies aimed at the treatment of NAFLD.</description><identifier>ISSN: 1930-7381</identifier><identifier>EISSN: 1930-739X</identifier><identifier>DOI: 10.1002/oby.22964</identifier><identifier>PMID: 32893456</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Biopsy ; Carbohydrates ; Cytokines ; Diabetes ; Diet ; Disease prevention ; Drug therapy ; Exercise ; Fatty acids ; Fitness training programs ; Gastrointestinal surgery ; Humans ; Inflammation ; Insulin resistance ; Lifestyles ; Liver diseases ; Metabolism ; Non-alcoholic Fatty Liver Disease - diet therapy ; Non-alcoholic Fatty Liver Disease - physiopathology ; Non-alcoholic Fatty Liver Disease - prevention &amp; control ; Obesity ; Oxidative stress ; Paleolithic ; Pathophysiology ; Popularity ; Weight control</subject><ispartof>Obesity (Silver Spring, Md.), 2020-10, Vol.28 (10), p.1843-1852</ispartof><rights>2020 The Obesity Society.</rights><rights>Copyright Blackwell Publishing Ltd. Oct 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4434-d4408e5cd457e54dafe02cab7006abb7dd336ff271aea131319db580b1cede8f3</citedby><cites>FETCH-LOGICAL-c4434-d4408e5cd457e54dafe02cab7006abb7dd336ff271aea131319db580b1cede8f3</cites><orcidid>0000-0003-4432-6638 ; 0000-0002-6365-7718 ; 0000-0001-9908-7123</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Foby.22964$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Foby.22964$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,777,781,882,1412,1428,27905,27906,45555,45556,46390,46814</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32893456$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moore, Mary P.</creatorcontrib><creatorcontrib>Cunningham, Rory P.</creatorcontrib><creatorcontrib>Dashek, Ryan J.</creatorcontrib><creatorcontrib>Mucinski, Justine M.</creatorcontrib><creatorcontrib>Rector, R. Scott</creatorcontrib><title>A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD</title><title>Obesity (Silver Spring, Md.)</title><addtitle>Obesity (Silver Spring)</addtitle><description>Nonalcoholic fatty liver disease (NAFLD) is a major health problem, and its prevalence has increased in recent years, concurrent with rising rates of obesity and other metabolic diseases. Currently, there are no FDA‐approved pharmacological therapies for NAFLD, and lifestyle interventions, including weight loss and exercise, remain the cornerstones for treatment. Manipulating diet composition and eating patterns may be a sustainable approach to NAFLD treatment. Dietary strategies including Paleolithic, ketogenic, Mediterranean, high‐protein, plant‐based, low‐carbohydrate, and intermittent fasting diets have become increasingly popular because of their purported benefits on metabolic disease. This review highlights what is currently known about these popular dietary approaches in the management of NAFLD in clinical populations with mechanistic insight from animal studies. It also identifies key knowledge gaps to better inform future preclinical and clinical studies aimed at the treatment of NAFLD.</description><subject>Biopsy</subject><subject>Carbohydrates</subject><subject>Cytokines</subject><subject>Diabetes</subject><subject>Diet</subject><subject>Disease prevention</subject><subject>Drug therapy</subject><subject>Exercise</subject><subject>Fatty acids</subject><subject>Fitness training programs</subject><subject>Gastrointestinal surgery</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Insulin resistance</subject><subject>Lifestyles</subject><subject>Liver diseases</subject><subject>Metabolism</subject><subject>Non-alcoholic Fatty Liver Disease - diet therapy</subject><subject>Non-alcoholic Fatty Liver Disease - physiopathology</subject><subject>Non-alcoholic Fatty Liver Disease - prevention &amp; control</subject><subject>Obesity</subject><subject>Oxidative stress</subject><subject>Paleolithic</subject><subject>Pathophysiology</subject><subject>Popularity</subject><subject>Weight control</subject><issn>1930-7381</issn><issn>1930-739X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kV1LwzAUhoMofkwv_AMS8EYv5vLVpr1R5uZUHE5QQa9C2pxqpWtm0k32741OhwqSixOSh4f38CK0S8kRJYR1bDY_YiyNxQrapCknbcnTh9XlPaEbaMv7F0JETCK6jjY4S1IuongTXXXxQBvcWBumO8H9Ehrt5vi2cbqBpxI8LqzDzTPgGwczqJvS1ljXBt850M04PGBb4OvuYNjfRmuFrjzsfM0Wuh-c3fUu2sPR-WWvO2znQnDRNkKQBKLciEhCJIwugLBcZ5KQWGeZNIbzuCiYpBo05eGkJosSktEcDCQFb6HjhXcyzcZg8pDB6UpNXDkO0ZXVpfr9U5fP6snOlIwoFYwFwcGXwNnXKfhGjUufQ1XpGuzUKxYSxrHkPAno_h_0xU5dHdb7oGLJZJrSQB0uqNxZ7x0UyzCUqI-KVKhIfVYU2L2f6ZfkdycB6CyAt7KC-f8mNTp9XCjfASJDmog</recordid><startdate>202010</startdate><enddate>202010</enddate><creator>Moore, Mary P.</creator><creator>Cunningham, Rory P.</creator><creator>Dashek, Ryan J.</creator><creator>Mucinski, Justine M.</creator><creator>Rector, R. Scott</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4432-6638</orcidid><orcidid>https://orcid.org/0000-0002-6365-7718</orcidid><orcidid>https://orcid.org/0000-0001-9908-7123</orcidid></search><sort><creationdate>202010</creationdate><title>A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD</title><author>Moore, Mary P. ; Cunningham, Rory P. ; Dashek, Ryan J. ; Mucinski, Justine M. ; Rector, R. Scott</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4434-d4408e5cd457e54dafe02cab7006abb7dd336ff271aea131319db580b1cede8f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Biopsy</topic><topic>Carbohydrates</topic><topic>Cytokines</topic><topic>Diabetes</topic><topic>Diet</topic><topic>Disease prevention</topic><topic>Drug therapy</topic><topic>Exercise</topic><topic>Fatty acids</topic><topic>Fitness training programs</topic><topic>Gastrointestinal surgery</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Insulin resistance</topic><topic>Lifestyles</topic><topic>Liver diseases</topic><topic>Metabolism</topic><topic>Non-alcoholic Fatty Liver Disease - diet therapy</topic><topic>Non-alcoholic Fatty Liver Disease - physiopathology</topic><topic>Non-alcoholic Fatty Liver Disease - prevention &amp; control</topic><topic>Obesity</topic><topic>Oxidative stress</topic><topic>Paleolithic</topic><topic>Pathophysiology</topic><topic>Popularity</topic><topic>Weight control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moore, Mary P.</creatorcontrib><creatorcontrib>Cunningham, Rory P.</creatorcontrib><creatorcontrib>Dashek, Ryan J.</creatorcontrib><creatorcontrib>Mucinski, Justine M.</creatorcontrib><creatorcontrib>Rector, R. Scott</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Obesity (Silver Spring, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moore, Mary P.</au><au>Cunningham, Rory P.</au><au>Dashek, Ryan J.</au><au>Mucinski, Justine M.</au><au>Rector, R. Scott</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD</atitle><jtitle>Obesity (Silver Spring, Md.)</jtitle><addtitle>Obesity (Silver Spring)</addtitle><date>2020-10</date><risdate>2020</risdate><volume>28</volume><issue>10</issue><spage>1843</spage><epage>1852</epage><pages>1843-1852</pages><issn>1930-7381</issn><eissn>1930-739X</eissn><abstract>Nonalcoholic fatty liver disease (NAFLD) is a major health problem, and its prevalence has increased in recent years, concurrent with rising rates of obesity and other metabolic diseases. Currently, there are no FDA‐approved pharmacological therapies for NAFLD, and lifestyle interventions, including weight loss and exercise, remain the cornerstones for treatment. Manipulating diet composition and eating patterns may be a sustainable approach to NAFLD treatment. Dietary strategies including Paleolithic, ketogenic, Mediterranean, high‐protein, plant‐based, low‐carbohydrate, and intermittent fasting diets have become increasingly popular because of their purported benefits on metabolic disease. This review highlights what is currently known about these popular dietary approaches in the management of NAFLD in clinical populations with mechanistic insight from animal studies. It also identifies key knowledge gaps to better inform future preclinical and clinical studies aimed at the treatment of NAFLD.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>32893456</pmid><doi>10.1002/oby.22964</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-4432-6638</orcidid><orcidid>https://orcid.org/0000-0002-6365-7718</orcidid><orcidid>https://orcid.org/0000-0001-9908-7123</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1930-7381
ispartof Obesity (Silver Spring, Md.), 2020-10, Vol.28 (10), p.1843-1852
issn 1930-7381
1930-739X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7511422
source MEDLINE; Wiley Free Archive; Wiley Online Library Journals Frontfile Complete
subjects Biopsy
Carbohydrates
Cytokines
Diabetes
Diet
Disease prevention
Drug therapy
Exercise
Fatty acids
Fitness training programs
Gastrointestinal surgery
Humans
Inflammation
Insulin resistance
Lifestyles
Liver diseases
Metabolism
Non-alcoholic Fatty Liver Disease - diet therapy
Non-alcoholic Fatty Liver Disease - physiopathology
Non-alcoholic Fatty Liver Disease - prevention & control
Obesity
Oxidative stress
Paleolithic
Pathophysiology
Popularity
Weight control
title A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T18%3A57%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Fad%20too%20Far?%20Dietary%20Strategies%20for%20the%20Prevention%20and%20Treatment%20of%20NAFLD&rft.jtitle=Obesity%20(Silver%20Spring,%20Md.)&rft.au=Moore,%20Mary%20P.&rft.date=2020-10&rft.volume=28&rft.issue=10&rft.spage=1843&rft.epage=1852&rft.pages=1843-1852&rft.issn=1930-7381&rft.eissn=1930-739X&rft_id=info:doi/10.1002/oby.22964&rft_dat=%3Cproquest_pubme%3E2446727991%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2446727991&rft_id=info:pmid/32893456&rfr_iscdi=true